Market Place
Sourcing Support
Heron Announces FDA Approval for Zynrelef
25 Sep 2024 //
PR NEWSWIRE
FDA Accepts Axsome`s AXS-07 NDA Resubmission For Migraine
04 Sep 2024 //
GLOBENEWSWIRE
ZYNRELEF Included As Qualifying Product Under Proposed Non-Opioid Policy
15 Jul 2024 //
PR NEWSWIRE
Heron`s ZYNRELEF Vial Access Needle Application Accepted
02 Jul 2024 //
PR NEWSWIRE
Ascent`s Generic Meloxicam Receives Approval in the U.S.
07 Jun 2023 //
FDA
Heron Therapeutics Announces Filing of an Efficacy Supplement for ZYNRELEF
29 Dec 2022 //
PR NEWSWIRE
Recro Pharma Will Pay $1.4 Million Under Shareholder Settlement
04 Dec 2022 //
BLOOMBERGLAW
Enforcement Report - Week of August 24, 2022
24 Aug 2022 //
FDA
Baudax receives notice of allowance for U.S. Patent Application covering ANJESO
22 Aug 2022 //
GLOBENEWSWIRE
FDA approves expansion for ZYNRELEF
10 Dec 2021 //
PHARMAFILE
Heron Announces FDA Approval of Significant Indication Expansion for ZYNRELEF
09 Dec 2021 //
PRNEWSWIRE
US FDA accepts Axsome Therapeutics’ NDA filing for AXS-07 to treat migraine
16 Sep 2021 //
PHARMABIZ
Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-07
14 Sep 2021 //
GLOBENEWSWIRE
Heron`s Zynrelef could hit blockbuster heights, analysts predict
15 May 2021 //
FIERCE PHARMA
Lupin launches US FDA approved generic Vivlodex capsules
28 Dec 2020 //
PHARMABIZ
Lupin launches US FDA approved generic Vivlodex capsules
28 Dec 2020 //
PHARMABIZ
Axsome Therapeutics Presents New Data of AXS-07
24 Sep 2020 //
GLOBENEWSWIRE
Heron Therapeutics Announces Outcome of FDA Type A Meeting to Discuss HTX-011
08 Sep 2020 //
PRESS RELEASE
Baudax Bio Announces Presentation of New Phase IIIb ANJESO® Data
30 Jul 2020 //
GLOBENEWSWIRE
EMA: Thumbs up for 11, down for 2 new medicines
25 Jul 2020 //
RAPS
Baudax Bio Secures Pharmacy Supplier Agreement with Vizient Inc. for ANJESO®
20 Jul 2020 //
GLOBENEWSWIRE
Lupin Ltd`s Generic Meloxicam Receives Approval In US
05 Jun 2020 //
FDA
Heron Announces Publication of Results from Study 209 2b Study of HTX-011
04 Jun 2020 //
PRNEWSWIRE
Baudax Bio Secures $50 Million Credit Facility
01 Jun 2020 //
GLOBENEWSWIRE
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 17-18
20 Mar 2020 //
EMA
Axsome Completes Patient Enrollment in the INTERCEPT Phase 3 Trial of AXS-07
20 Feb 2020 //
GLOBENEWSWIRE
Axsome Therapeutics
31 Dec 2019 //
GLOBENEWSWIRE
FDA Grants Appeal to Recro Pharma for IV Meloxicam New Drug Application
09 Oct 2019 //
PRESS RELEASE
Recro Pharma Amends IV Meloxicam License Agreement with Alkermes
28 Dec 2018 //
CONTRACT PHARMA
Novitium Pharma` Generic Meloxicam Receives Tentative Approval in US
22 Nov 2018 //
FDA
Committee for Medicinal Products for Veterinary Use meeting of 11-13 Sep 18
14 Sep 2018 //
EMA
Boehringer Ingelheim expands European Metacam indication to guinea pigs
19 Jun 2018 //
PHARMABIZ
Vivlodex® Brand Meloxicam : Iceutica v. Novitium Pharma
20 Apr 2018 //
PATENT LITIGATION
Mylan to Leverage its World-Class Scientific Platform to Develop Meloxicam
11 Apr 2018 //
PR NEWSWIRE
Many people take dangerously high amounts of ibuprofen
09 Feb 2018 //
REUTERS
Enforcement Report - Week of October 18, 2017
18 Oct 2017 //
FDA
FDA Confirms Paragraph IV Patent Challenge of Vivlodex (Meloxicam Capsules)
05 Jun 2017 //
FDA
Iroko Pharmaceuticals Announces Key Patent for VIVLODEX®
06 Jan 2017 //
PR NEWSWIRE
Recro Pharma Reports Positive Results for Clinical Trial of IV Meloxicam
28 Nov 2016 //
GLOBENEWSWIRE
Recro Pharma`s intravenous painkiller succeeds in trial, shares soar
27 Jul 2016 //
REUTERS
New Multi-Particle Systems for Colon-Targeted Meloxicam
31 May 2016 //
PHARMA-EXCIPIENTS
Nano-Crystalline Cellulose as a Novel Tablet Excipient for Improving Solubility
07 Mar 2016 //
PHARMA-EXCIPIENTS
VIVLODEX™ Now Available in U.S. Pharmacies for Management of Osteoarthritis Pain
16 Feb 2016 //
PR NEWSWIRE
Recro Pharma`s lead painkiller succeeds in mid-stage trial
07 Jan 2016 //
REUTERS
